No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Spinal Elements ® Announces Full Commercial Launch of Luna® XD and Orbit™ Systems

Editor: What To Know

  • The novel articulating rotary design allows the instrumentation's working end to evacuate the full area of the disc necessary for implantation of the Luna XD circular device.
  • Spinal Elements will feature the Luna XD and Orbit systems at the upcoming meeting of the North American Spine Society in Boston on September 29 through October 2, 2021.
  • The Orbit system consists of articulating and rotating discectomy instrumentation that uses a minimal, posterior incision and/or MIS tubular approach to achieve efficient disruption and removal of disc tissue while preparing the endplates for fusion.

Spinal Elements, a spine technology company, today announced the full commercial launch of the Luna XD multi-expandable lumbar interbody fusion device and Orbit articulating discectomy systems. Luna XD and Orbit have been integrated into Spinal Elements as the newest technologies in its MIS Ultra platform of products and procedural solutions.

The Orbit system consists of articulating and rotating discectomy instrumentation that uses a minimal, posterior incision and/or MIS tubular approach to achieve efficient disruption and removal of disc tissue while preparing the endplates for fusion. The novel articulating rotary design allows the instrumentation’s working end to evacuate the full area of the disc necessary for implantation of the Luna XD circular device.

The Luna XD system allows an ALIF-sized, circular implant to be surgically delivered to the intervertebral space through a posterior, minimally invasive access point. Once inserted, the Luna XD implant first expands horizontally to cover the disc footprint, creating a stable foundation. The implant then expands vertically up to 16mm to restore disc height. Furthermore, the device includes up to 12° of lordosis to aid in the restoration of sagittal alignment.

Jason Blain, CEO of Spinal Elements, stated, “We are thrilled at what we have seen over the last several months with the introduction of the Luna XD and Orbit technologies. We are particularly looking forward to delivering these innovative and differentiated technologies to an even broader group of customers, many of whom have already been trained and are now adopting the products into their daily practice.”

“This is an exciting time to be associated with these innovative technologies,” stated Andrew White, M.D., Chief of Spine Surgery at Beth Israel Deaconess Medical Center, Boston, MA. “The Luna XD interbody and the Orbit Discectomy system help me to achieve my desired surgical goals of restoring interbody height and restoring lordosis, thereby alleviating radicular pain. The stability provided by the multi-expandable footprint gives me a lot of confidence that the restoration of interbody height and alignment will be durable. I have been able to do cases with Luna XD that would have previously required anterior and posterior surgery with ALIF/PLIF. It really has expanded what I can offer to patients with a minimally invasive treatment.”

Spinal Elements will feature the Luna XD and Orbit systems at the upcoming meeting of the North American Spine Society in Boston on September 29 through October 2, 2021.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy